Latest Content

Kidney Cancer Awareness Month Highlights Advocacy and Early Detection

March 27th 2025, 9:00pm

By Ryan Scott

Article

March is Kidney Cancer Awareness Month, highlighting the disease, early detection and and patient advocacy, with voices like Sid Sadler raising awareness.

Clinical Trial to Evaluate Opdivo, Opdualag in Glioblastoma

March 27th 2025, 8:53pm

By Georgina Long

Video

The phase 2 GIANT trial will evaluate Opdivo with or without relatlimab in IDH-wildtype newly diagnosed glioblastoma.

Quadruplet Regimen Preferable to Triplets in Multiple Myeloma

March 27th 2025, 7:00pm

By Alex Biese

Article

Dr. Cesar Rodriguez discussed treatment advancements for multiple myeloma during a CURE Educated Patient® Summit.

Snow, A Wig, and Memories After My Breast Cancer Diagnosis

March 27th 2025, 5:00pm

By Bonnie Annis

Article

Cancer memories often sneak up on me when I least expect them to.

CAN-2409 Elicits Survival Responses In NSCLC

March 27th 2025, 4:00pm

By Alex Biese

Article

Treatment with CAN-2409, an off-the-shelf immunotherapy, elicited responses among patients with pretreated stage 3/4 non–small cell lung cancer.

Itolizumab Shows Long-Term Treatment Benefits in Acute GVHD

March 27th 2025, 3:00pm

By Ryan Scott

Article

Although itolizumab did not improve response rates at Day 29 for patients with acute GVHD, the therapy showed significant benefits in long-term outcomes.

Rina-S Generates Antitumor Activity in Heavily Pretreated Ovarian Cancer

March 27th 2025, 1:00pm

By Dr. Elizabeth K. Lee

Video

Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the phase 2 RAINFOL-01 study.

A VXM01 Vaccine Combination Generates Safe Responses in Glioblastoma

March 26th 2025, 9:00pm

By Ryan Scott

Article

Treatment with VXM01, an investigational vaccine, plus Bavencio demonstrated both safety and tolerability in patients with recurrent glioblastoma.

A Patient Advocate Highlights Kidney Cancer Awareness and Specialized Care

March 26th 2025, 8:00pm

By Ryan Scott

Video

Sid Sadler discusses kidney cancer awareness, patient advocacy and the need for specialized care to improve access to treatments and clinical trials.

Communication is Key When Transitioning Multiple Myeloma Care

March 26th 2025, 7:00pm

By Alex Biese

Article

A panel of experts discussed the transition of care between community and academic centers at the CURE Educated Patient Multiple Myeloma Summit.

Surviving Scans While Surviving Breast Cancer

March 26th 2025, 5:00pm

By Felicia Mitchell

Article

Survivors facing new medical concerns may fear the unknown, but perseverance is possible as they navigate unexpected challenges in their new normal.

Progress Reported in Phase 1 Trial of CLD-101 for Recurrent Glioma

March 26th 2025, 4:00pm

By Spencer Feldman

Article

A progress report for a phase 1 trial of CLD-101 in recurrent glioma shows safety and feasibility at multiple intracerebral doses.

FDA Approves Cabometyx for Some Neuroendocrine Tumors

March 26th 2025, 1:44pm

By Alex Biese

Article

The FDA has approved Cabometyx for some patients 12 years old and older with pancreatic neuroendocrine tumors and extra-pancreatic neuroendocrine tumors.

Navigating a Colorectal Cancer Diagnosis at a Young Age

March 26th 2025, 1:00pm

By Ryan Scott

Article

Melissa Ursini discussed her experience with a colorectal cancer diagnosis at age 37, highlighting her insights during Colorectal Cancer Awareness Month.

EU Approves Rytelo for Transfusion-Dependent Anemia in Low-Risk MDS

March 25th 2025, 9:00pm

By Ryan Scott

Article

The European Commission has approved Rytelo treatment in transfusion-dependent anemia due to very low–, low– or intermediate-risk myelodysplastic syndrome.